Study of colorectal metachronous neoplastic lesions
DOI:
https://doi.org/10.23938/ASSN.0135Keywords:
Cáncer colo-rectal. Carcinoma metacrónico. Adenoma metacrónico.Abstract
Background. To analyse the frequency and characteristics of metachronous neoplastic lesions, carcinomas and adenomas, following resection of colorectal cancer. Patients and methods. We reviewed 382 patients subjected to RCC operations and followed up through complete colonoscopies in two hospitals in our province. We analysed the metachronous lesions registered, evaluating their localisation, time of diagnosis, histology, number and size. We studied the frequency of early adenomas (12 months), comparing their size with the rest of the lesions. Results. The average follow-up was 48 months (12-112), with 2.74±1.47 colonoscopies/case. We diagnosed 7 metachronous cancers (1.8%), 4 of them in stage I. The average time until their diagnosis was 24 months (13-54). We registered metachronous adenomas in 162 cases (42.4%), without differences between the two hospitals: 42.1% vs. 43.8% (p=0.88). Six point three percent of the patients presented advanced adenomas. In 164 cases where the control was carried out after 12 months, the incidence of adenomas was 24%. In the majority of cases, the adenomas were sole (60.8%) and smaller than 5 mm (68.5%). In 55.5% of the cases with polyps, some had a proximal localisation. Diagnosis was made on the 1st exploration (56.2%), the 2nd (27.8%) or the 3rd (9%). Average time until diagnosis was 21 months (12-112) for simple adenoma and 35 (12-112) for advanced adenoma. Conclusions. Our follow up made it possible to apply a theoretically curative treatment in the majority of the metachronous carcinomas diagnosed. The high incidence of adenomas and the frequent proximal localisation make a follow up with complete colonoscopies necessary, which must be started one year after the operation and can become less strict following three consecutive explorations without polyps.Downloads
References
1. WEITZ J, KOCH M, DEBUS J, HÖHLER T, GALLE PR, BÜCHLER MW. Colorectal cancer. Lancet 2005; 365: 153-165.
https://doi.org/10.1016/S0140-6736(05)17706-X
2. RUSSO MW, WEI JT, THINY MT, GANGAROSA LM, BROWN A, RINGEL Y et al. Digestive and liver diseases statistics. Gastroenterology 2004; 126: 1448-1453.
https://doi.org/10.1053/j.gastro.2004.01.025
3. ARDANAZ E, MORENO-IRIBAS C, PÉREZ DE RADA ME, EZPONDA C, FLORISTÁN Y, NAVARIDAS N et al. Incidencia y mortalidad por cáncer en Navarra, 1998-2002. Evolución en los últimos 30 años. An Sist Sanit Navar 2007; 30: 245-270.
https://doi.org/10.4321/S1137-66272007000300009
4. RODRIGO L, RIESTRA S. Dieta y cáncer de colon. Rev Esp Enferm Dig 2007; 99: 183-189.
https://doi.org/10.4321/S1130-01082007000400001
5. CASTELLS A, MARZO M, BELLAS B, AMADOR FJ, LANAS A, MASCORT JJ et al. Guía de práctica clínica en prevención del cáncer colo-rectal. Gastroenterol Hepatol 2004; 27: 573-634.
https://doi.org/10.1157/13069131
6. PIÑOL V, ANDREU M, CASTELLS A, PAYA A, BESSA X, JOVER R. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Col Rectum 2004; 47: 1192-2000.
https://doi.org/10.1007/s10350-004-0562-7
7. BORDA A, MARTÍNEZ PEÑUELA J, PRIETO C, MUÑOZ M, CARRETERO C, BORDA F. Estudio de la frecuencia, distribución y rendimiento diagnóstico en las lesiones neoplásicas sincrónicas del carcinoma colo-rectal. An Sist Sanit Navar 2008; 31: 43-52.
https://doi.org/10.4321/S1137-66272008000100004
8. SHITOH K, KONISHI F, MIYAKURA Y, TOGASHI K, OKAMOTO T, NAGAI H. Microsatellite instability as a marker in predicting metachronous multiple colorectal carcinomas after surgery: a cohort-like study. Dis Colon Rectum 2002; 45: 329-333.
https://doi.org/10.1007/s10350-004-6177-1
9. STIGLIANO V, FRACASSO P, GRASSI A, LAPENTA R, CITARDA F, TOMASELLI G et al. Endoscopic follow-up in resected colorectal cancer patients. J Exp Clin Cancer Res 2000; 19: 145-148.
10. LAN YT, LIN JK, LI AF, LIN TC, CHEN WS, JIANG JK et al. Metachronous colorectal cancer: Necessity of post-operative colonoscopic surveillance. Int J Colorectal Dis 2005; 20: 121-125.
https://doi.org/10.1007/s00384-004-0635-z
11. CHEN HS, SHEEN-CHEN SM. Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum 2000; 43: 1093-1099.
https://doi.org/10.1007/BF02236556
12. TSANTILAS D, NTINAS A, PETRAS P, ZAMBAS N, AL MOGRAMBI S, FRANGANDREAS G et al. Metachronous colorectal adenocarcinomas. Tech Coloproctol 2004; 8: 1: 202-204.
https://doi.org/10.1007/s10151-004-0157-2
13. GSCHWANTLER M, KRIWANEK S, LANGNER E, GÖRITZER B, SCHRUTKA-KÖLBL C, BROWNSTONE E et al High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 2002; 14: 183-188.
https://doi.org/10.1097/00042737-200202000-00013
14. BALLESTÉ B, BESSA X, PIÑOL V, CASTELLVÍ-BEL S, CASTELLS A, ALENDA C et al. Detection of metachronous neoplasm in the colorectal cancer patients. Identification of risk factors. Dis Colon Rectum 2007; 50: 971-980.
https://doi.org/10.1007/s10350-007-0237-2
15. FAJOBI O, YIU CY, SEN-GUPTA SB, BOULOS PB. Metachronous colorectal cancers. Br J Surg 1998; 85: 897-901.
https://doi.org/10.1046/j.1365-2168.1998.00800.x
16. YAMAZAKI T, TAKII Y, OKAMOTO H, SAKAI Y, HATAKEYAMA K. What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 1997; 40: 935-938.
https://doi.org/10.1007/BF02051201
17. NAH BK, KIM SM, LEE YS, YANG HW, SEO SW, SUNG JK et al. Pattern of metachronous adenoma after colorectal cancer surgery. Korean J Gastroenterol 2004; 44: 212-216.
18. KULLING D, CHRIST AD, KARAASLAN N, FRIED M, BAUERFEIND P. The presence of more than two index adenomas is the strongest predictor of metachronous colon adenomas. Swiss Med Wkly 2002; 132: 139-142.
https://doi.org/10.4414/smw.2002.09877
19. CALI RL, PITSCH RM, THORSON AG, WATSON P, TAPIA P, BLATCHFORD GJ et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993; 36: 388-393.
https://doi.org/10.1007/BF02053945
20. CHO JH, LEE SK, KIM TI, KIM WH. Characteristics and risk factors of synchronous and metachronous polyp in colorectal cancer. Korean J Gastroenterol 2004; 43: 168.
21. RODRÍGUEZ-MORANTA F, SALÓ J, ARCUSA A, BOADAS J, PIÑOL V, BESSA X et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006; 24: 386-393.
https://doi.org/10.1200/JCO.2005.02.0826
22. AGREZ MV, READY R, ILSTRUP D, BEART RW. Metachronous colorectal malignancies. Dis Colon Rectum 1982; 25: 569-574.
https://doi.org/10.1007/BF02564169
23. FINAN PJ, RITCHIE JK, HAWLEY PR. Synchronous and "early" metachronous carcinomas of the colon and rectum. Br J Surg 1987; 74: 945-947.
https://doi.org/10.1002/bjs.1800741021
24. WARREN S, GATES O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932 ; 16: 1358-1414.
25. KAIBARA N, KOGA S, KINNAI D. Synchronous and metachronous malignancies of the colon and rectum in Japan with special reference to a coexisting early cancer. Cancer 1984; 54: 1870-1874.
https://doi.org/10.1002/1097-0142(19841101)54:9<1870::AID-CNCR2820540917>3.0.CO;2-5
26. MACGIVILLIVRAY DC, SWARTZ SE, ROBINSON AM, CRUESS DF, SMITH LE. Adenocarcinoma of the colon and rectum in patiens less than 40 years of age. Surg Gynecol Obstet 1991; 172: 1-7.
27. BLACHAR A, SOSNA J. CT colonography (virtual colonoscopy): technique, indications and performance. Digestion 2007; 76: 34-41.
https://doi.org/10.1159/000108392
28. MACKEN E, MOREELS T, PELCKMANS M, BAERT D, REYNAERT H,DELOOZE D et al Quality assurance and recommendations for quality assessment of screening colonoscopy in Belgium. Acta Gastroenterol Bel 2009; 72: 17-25.
29. BRESSLER B, PASZAT LF, CHEN Z, ROTHWELL DM, VINDEN C, RABENECH L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007; 132: 96-102.
https://doi.org/10.1053/j.gastro.2006.10.027
30. GREEN RJ, METLAY JP, PROPERT K, CATALANO PJ, MACDONALD JS, MAYER RJ et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of intergroup 0089. Ann Intern Med 2002; 136: 261-269.
https://doi.org/10.7326/0003-4819-136-4-200202190-00005
31. FUKUTUMI Y, MORIWAKI H, NAGASE S, TAJIKA M, NAITO T, MIWA Y et al. Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypectomy. J Cancer Res Clin Oncol 2002; 128: 569-574.
https://doi.org/10.1007/s00432-002-0375-9
32. RAJARATNAM SG, DENNETT ER. Development of metachronous neoplasms alter colorrectal cancer resection: absence of synchronous neoplams predicts a lower risk. N Z Med J 2009; 122: 61-66.
33. BOUVIER AM, LATOURNERIE M, JOOSTE V, LEPAGE C, COTTET V, FAIVRE J. The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up. Eur J Cancer 2008; 44: 522-527.
https://doi.org/10.1016/j.ejca.2008.01.007
34. BULOW S, SVENDSEN LB, MELLEMGAARD A. Metachronous colorectal carcinoma. Br J Surg 1990; 77: 502-505.
https://doi.org/10.1002/bjs.1800770509
35. CERDÁN J, TORRES-MELERO J, DÍEZ M, BALSA T, BALIBREA JL. Adenocarcinomas colo-rectales metacrónicos. Rev Esp Enferm Digest 1996; 88: 655-659.
36. NUSKO G, HAHN EG, MANSMANN U. Characteristics of metachronous colorrectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence. Scand J Gastroenterol 2009; 44: 736-744.
https://doi.org/10.1080/00365520902770078
37. CAPPELL MS, FORDE KA. Spatial clustering of multiple hyperplastic, adenomatous, and malignant colonic polyps in individual patients. Dis Colon Rectum 1989; 32: 641-652.
https://doi.org/10.1007/BF02555767
38. OLSEN HW, LAWRENCE WA, SNOOK CW, MUTCH WM. Review of recurrent polyps and cancer in 500 patients with initial colonoscopy for polyps. Dis Colon Rectum 1988; 31: 222-227.
https://doi.org/10.1007/BF02552551
39. NUSKO G, MANSMANN U, WIEST G, BRUECKL W, KIRCHNER T, HAHN EG et al. Right-sided shift found in metachronous colorectal adenomas. Endoscopy 2001; 33: 574-579.
https://doi.org/10.1055/s-2001-15379
40. EVERS BM, MULLINS RJ, MATHEWS TH, BROGHAMER WL, POLK HC. Multiple adenocarcinomas of the colon and rectum. An analysis of incidences and current trends. Dis Colon Rectum 1988; 31: 518-522.
https://doi.org/10.1007/BF02553724
41. GRIFFIOEN G, BOSMAN FT, VERSPAGET HW, SIER KF, BIEMOND I, LAMERS CB. Comparative evaluation of carcinoembryonic antigen, secretory component, and mucins in index and metachronous adenomas of the colorectum. Gastroenterology 1991; 101: 919-926.
https://doi.org/10.1016/0016-5085(91)90716-X
42. HOFSTAD B, VATN MH, ANDERSEN SN, HUITFELDT HS, ROGNUM T, LARSEN S et al. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut 1996; 39: 449-456.
https://doi.org/10.1136/gut.39.3.449
43. TADA M, MISAKI F, DAWAI K. Growth rates of colorectal carcinoma and adenoma by roentgenologic follow-up observations. Gastroenterol Jpn 1984; 19: 550-555.
https://doi.org/10.1007/BF02793869
44. BERSENTES K, FENNERTY MB, SAMPLINER RE, GAREWAL HS. Lack of spontaneus regression of tubular adenomas in two years of follow-up. Am J Gastroenterol 1997; 92: 1117-1120.
45. HOFSTAD B, TATN M, LARSEN S, OSNES M. Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection. Scand J Gastroenterol 1994; 29: 640-645.
https://doi.org/10.3109/00365529409092485
46. HERESBACH D, BARRIOZ T, LAPALUS MG, COUMAROS D, BAURET P, POTIER P et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 2008; 40: 284-290.
https://doi.org/10.1055/s-2007-995618
47. VAN RIJN JC, REITSMA JB, STOKER J, BOSSUYT PM, VAN DEVENTER SJ, DEKKER E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006; 101: 343-350.
https://doi.org/10.1111/j.1572-0241.2006.00390.x
48. REX DK, CUTLER CS, LEMMEL CT, RAHMANI EY, CLARK DW et al. Colonoscopic missrates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24-28.
https://doi.org/10.1016/S0016-5085(97)70214-2
49. RÜSCHOFF J, AUST D, HARTMANN A. Colorectal serrated adenoma: diagnostic criteria and clinical implications. Verh Dtsch Ges Pathol 2007; 91: 119-125.
50. SAINI SD, KIM HM, SCHOENFELD P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 2006; 64: 614-626.
https://doi.org/10.1016/j.gie.2006.06.057
51. MCFALL MR, WOODS WG, MILES WF. Colonoscopic surveillance after curative colorectal resection: results of an empirical surveillance programme. Colorectal Dis 2003; 5: 131-132.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.


